Iatrogenic Air in the Cavernous Sinus
AJR 159:189-190, Adams,M.,et al, 1992
Toxoplasma Encephalitis in Patients with the Acquired Immunodeficiency Syndrome
Medicine 71:224-239, Renold,C.,et al, 1992
Low-Dose Trimethoprim-Sulfamethoxazole Prophylaxis for Toxoplasmic Encephalitis in Patients with AIDS
Ann Int Med 117:106-111, 163-1641992., Carr,A.,et al, 1992
Efficacy of Atovaquone in Treatment of Toxoplasmosis in Patients with AIDS
Lancet 340:637-638, Kovacs,J.A., 1992
Intracranial Tuberculosis in AIDS:CT and MRI Findings
et al Neuroradiology 34:11-14, Villoria,M.F., 1992
Effect of Calcitonin-Gene-Related Peptide in Pts with Delayed Postop Cerebral Ischaemia after Aneurysmal SAH
Europ CGRP Study Group, Lancet 339:831-8341992., , 1992
The Preponderance of Posterior Circulatory Events is Independent of the Route of Cardiac Catheterization
Stroke 23:1358-1359, Keilson,G.R.,et al, 1992
Role of Ticlopidine for Prevention of Stroke
Stroke 23:912-916, Albers,G.W., 1992
Neurologic Events after Partial Exchange Transfusion for Priapism in Sickle Cell Disease
J Pediatr 120:882-885, Rackoff,W.R.,et al, 1992
Transient Global Amnesia after Cerebral Angiography with Iohexol
Neuroradiology 34:141-143, Juni,J.,et al, 1992
Postpartum Cerebral Angiopathy with Cerebral Infarction Due to Ergonovine Use
Stroke 23:1364-1366, Barinagarrementeria,F.,et al, 1992
The Risk of Stroke in Patients with Acute Myocardial Infarction after Thrombolytic and Antithrombotic Treatment
NEJM 327:1-6, Maggioni,A.P.,et al, 1992
Urgent Therapy for Stroke Part II, Pilot Study of Tissue Plasminogen Activator Administered 91-180 Minutes from Onset
Stroke 23:641-645, Haley,E.C.,et al, 1992
Urgent Therapy for Stroke Part I, Pilot Study of Tissue Plasminogen Activator Administered within 90 Minutes
Stroke 23:632-640, Brott,T.G.,et al, 1992
Intracranial Hemorrhage After Coronoary Thrombolysis with Tissue Plsminogen Activator
Am J Med 92:384-390, Kase,C.S.,et al, 1992
Recombinant Tissue Plasminogen Activator in Acute Thrombotic and Embolic Stroke
Ann Neurol 32:78-86, delZoppo,G.J.,et al, 1992
Toxicity and Deaths from 3, 4-Methylenedioxymethamphetamine ("ecstast")
Lancet 340:384-387, Henry,J.A.,et al, 1992
CNS Complications of Cocaine Abuse:Prevalence, Pathophysiology, and Neuroradiology
AJR 159:137-147, Brown,E.,et al, 1992
A Double-Blind, Renadomized, Crossover Trial of Pemoline in Fatigue Assoc with Multiple Sclerosis
Neurol 42:1468-1471, Weinshenker,B.G.,et al, 1992
Dysphagia After Botulinum Toxin Injections for Spasmodic Torticolli:Clinical and Radiologic Findings
Neurol 42:1307-1310, Comella,C.L.,et al, 1992
Rate and Types of Fractures in Corticosteroid-Treated Multiple Sclerosis Patinets
Neurol 42:1389-1391, Troiano,R.A.,et al, 1992
Clinicopath Conf
Infantile Striatonigral Regeneration, with Cerebellar Degeneration, Familial, Case 30-1992, NEJM 327, 261-1992., 1992
Chiari I Malformations:Clinical and Radiologic Reappraisal
Radiology 183:347-353, Elster,A.D.&Chen,M.Y.M., 1992
Valve Disease Associated with Ergot Alkaloid Use:Echocardiographic and Pathologic Correlations
Ann Int Med 117:50-52, Redfield,M.M.,et al, 1992
Lamotrigine
Lancet 339:1397-1400, Brodie,M.D., 1992
Treatment of Toxoplasmic Encephalitis in Patients with AIDS, Pyrimethamine & Clindamycin vs. Pyrimethamine & Sulfadiazine
Ann Int Med 116:33-43, Dannemann,B.,et al, 1992
Toxicity of Clindamycin as Prophylaxis for AIDS-Associated Toxoplasmic Encephalitis
Lancet 339:333-334, Jacobson,M.A.,et al, 1992
Therapy for Neurocysticercosis
Arch Neurol 49:290-294, Takayanagui,O.M.&Jardim,E., 1992
The Use of Transcranial Ultrasonography to Predict Stroke in Sickle Cell Disease
NEJM 326:605-610, 6371992., Adams,R.,et al, 1992
Early Computed Tomographic Findings for Thrombolytic Therapy in Patients with Acute Brain Embolism
Stroke 23:20-23, Okada,Y.,et al, 1992
Botulinum Toxin Therapy for Limb Dystonias
Neurol 42:627-630, Yoshimura,D.M.,et al, 1992
Unsuspected, Surreptitious Drug-Induced Parkinsonism
Neurol 42:459, Albanese,A.,et al, 1992
Tremor in MPTP-Induced Parkinsonism
Neurol 42:407-410, Tetrud,J.W.&Langston,J.W., 1992
GM-1 Ganglioside for Spinal-Cord Injury
NEJM 326:493, Schonhofer,P.S., 1992
Mechanical Restraint Use and Fall-Related Injuries Among Residents of Skilled Nursing Facilities
Ann Int Med 116:369-374, Tinetti,M.E.,et al, 1992
Adverse Events Following Pertussis and Rubella Vaccines, Summary of a Report of the Institute of Medicine
JAMA 267:392-396, Howson,C.P.&Fineberg,H.V., 1992
Presence of HTLV-I Proviral DNA in Central Nervous System of Patients with HTLV-I-Associated Myelopathy
Ann Neurol 31:39-45, Kira,J.,et al, 1992
Cerebral Infarction Complicating Intravenous Immunoglobulin Therapy for Polyneuritis Cranialis
Neurol 42:257-258, Silbert,P.L.,et al, 1992
Transient Neutropenia Induced by Intravenous Immune Globulin
NEJM 326:270-271, Grebenau,M.D., 1992
Brachial Plexopathy Associated with Interleukin-2 Therapy
Neurol 42:462-463, Loh,F.L.,et al, 1992
Nervous System Lyme Borreliosis-Revisited
Arch Neurol 49:102-107, Finkel,M.J.&Halperin,J.J., 1992
Invasion of the Central Nervous System by Borrelia Burgdorferi in Acute Disseminated Infection
JAMA 267:1364-1367, Luft,B.J.,et al, 1992
Chronic Neurodegenerative Disease Associated with HTLV-II Infection
Lancet 339:645-646, Hjelle,B.,et al, 1992
Multifocal Inflammatory Leukoencephalopathy with 5-Fluorouracil and Levamisole
Ann Neurol 31:262-267, Hook,C.C.,et al, 1992
Tamoxifen Retinopathy:A Rare But Serious Complication
BMJ 304:495-496, Bentley,C.R.,et al, 1992
Mortality in Patients with AIDS Treated with Either Foscarnet or Ganciclovir for CMV Retinitis
AIDS Res Group & AIDS Clin Trials Group, NEJM 326:213-220, 2642., , 1992
Idiopathic Hemiparetic Parkinsonism, A Syndrome Distinct from Idiopathic Parkinsonism
Lancet 339:149-150, DeKeyser,J.,et al, 1992
Deprenyl Effects of Levodopa Pharmacodynamics, Mood, and Free Radical Scavenging
Neurol 42:541-544, Baronti,F.,et al, 1992
Acute and Persistent Parkinsonism after Use of Diquat
Neurol 42:261-263, Sechi,G.P.,et al, 1992
Periodic Triphasic Waves in Levodopa-Induced Encephalopathy
Neurol 42:444-446, Neufeld,M.Y., 1992